Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

LUNG holding history

Pulmonx Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LUNG overviewAll 13F holders of LUNGFull Q2 2026 holdings

Shares (Q2 2026)
204,053
Value
$265.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LUNG by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026204,053$265.3K<0.1%−5,648−2.7%ReducedHolders
Q1 2026209,701$270.5K<0.1%+38,105+22.2%AddedHolders
Q4 2025171,596$379.2K<0.1%+90,304+111.1%AddedHolders
Q3 202581,292$131.7K<0.1%−194,603−70.5%ReducedHolders
Q2 2025275,895$714.6K<0.1%+192,833+232.2%AddedHolders
Q1 202583,062$559.0K<0.1%−118,776−58.8%ReducedHolders
Q4 2024201,838$1.37M<0.1%+180,665+853.3%AddedHolders
Q3 202421,173$175.5K<0.1%−1,462−6.5%ReducedHolders
Q2 202422,635$143.5K<0.1%−24,705−52.2%ReducedHolders
Q1 202447,340$438.8K<0.1%+13,665+40.6%AddedHolders
Q4 202333,675$429.4K<0.1%+9,624+40.0%AddedHolders
Q3 202324,051$248.4K<0.1%−2,226−8.5%ReducedHolders
Q2 202326,277$344.5K<0.1%−1,498−5.4%ReducedHolders
Q1 202327,775$310.5K<0.1%+14,986+117.2%AddedHolders
Q4 202212,789$107.8K<0.1%−391−3.0%ReducedHolders
Q3 202213,180$220.0K<0.1%+4,685+55.2%AddedHolders
Q2 20228,495$125.0K<0.1%−4,538−34.8%ReducedHolders
Q1 202213,033$324.0K<0.1%−2,142−14.1%ReducedHolders
Q4 202115,175$486.0K<0.1%+11,895+362.7%AddedHolders
Q3 20213,280$118.0K<0.1%+3,000+1,071.4%AddedHolders
Q2 2021280$12.0K<0.1%−4,254−93.8%ReducedHolders
Q1 20214,534$207.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.